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The recognition of adverse effects due to environmentl endocrine disruptors in humans and
wildlie has focused attention on the need forpredictive tools to select the mostlikel estrogenic
chemicals om a very large number ofchemicals for subsequent screening and/or testing for
potential environmental toxicity. Athree-dimensional quantitative structure-activityrelationship
(QSAR) model using comparative molecular field analysis (CoMFA) was constructed based on
relative binding affiity (RBA) data from an estrogen receptor (ER) bding assay using calf
uterine cytosoL. The model demonted significant correation ofthe caculted steric and dec-
trostatic fields with RBA andyieldedpredictions that agr well with experimental vlues over
theentire range ofRBAvalues. Analysis ofthe CoMFAthee-dimensional contourplots revealed
a consistent picture ofthe strctural features that are lagly responsible for the observed varia-
tions in RBA. Importandy, we established a correlation between the predicted RBA values for
calfER and their actual RBA values for human ER. These findins suggest amean to begin to
constuct a more compre ive strogen knowledge base by combining RBA assay data from
multiple species in 3D-QSAR based predictive models, which could then be used to screen
untested chemicals for their potential to bind to the ER. Another QSAR model was developed
based on classical phy emical descriptors generted using.the CODESSA (Comprehensive
Descriptors for Structural and Statistical Analysis) program.n The predictive ability of the
CoMFA model was superior to the corresponding CODESSA model. Key work CODESSA,
CoMFA, endocrine disruptos, estrogen receptor, estrogens, quataive strucuc-tivity rela-
tionships, QSAR, relative bindingaffinity, species-to-species rpolation, xenoestrogns.
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A significant number of compounds with a
broad diversity of chemical structures, pro-
duced both in nature and by man, have
estrogenic activity (1). Estrogens elicit many
cellular responses in target tissues and can
exert both positive and negative effects on
health and reproductive function. For exam-
ple, estrogens are used beneficially for fertili-
ty control (oral contraception) (2) and for
relief of menopausal symptoms (estrogen
replacement therapy) (3). The adverse devel-
opmental effects of diethylstilbestrol (DES)
demonstrate human fetal sensitivity to estro-
genic compounds (4), while other xenoe-
strogens appear to disrupt endocrine func-
tion in wildlife and in laboratory animals
(5,6). Recently, concern about the adverse
effects of chemical compounds with estro-
genic activity on humans and other species
has grown rapidly (7). Adverse effects on the
development of reproductive capacity is the
highest priority (8). Another manifest con-
cern is xenoestrogen involvement in some
common cancers in women (9). The emer-
gence of the endocrine disruptor issue has
resulted in new laws requiring evaluation of
some chemicals found in foods or water for
several types ofhormonal activity (10,11).
Seventy thousand or more chemicals
may ultimately need to be evaluated for
estrogenic activity, and methods need to be
developed to distinguish which of these
should have highest priority for entry into
the more expensive screening and testing
procedures.
Because the chemical structures of
xenoestrogens are highly diverse (12),
estrogenicity is not readily deduced from
simple inspection of chemical structure.
Therefore, risk assessments for estrogenic
chemicals are basically dependent on in
vivo assays (13), such as uterine weight
gain (14,15), which measures responses in
estrogen sensitive tissues, and multigenera-
tion studies, which assess reproductive per-
formance. Supporting data may come from
reporter gene assays (16), cell proliferation
assays (17), or from in vitro studies of
competition of estrogen binding to the
estrogen receptor (ER) (18). However,
many in vivo assays are labor-intensive,
time-consuming, and costly, which makes
them impractical for routine screening and
testing ofa large number ofchemicals.
Many estrogen responses are thought
to be mediated via estrogen binding to the
classical estrogen receptor (ER-a); this
mechanism is the basis for the correlation
between the ability of a chemical to com-
pete for estradiol binding to ER and to
induce estrogenic effects in vivo. Therefore,
the determination of the pharmacophoric
elements of ligands that bind to the ER is
crucial to understanding the biological
effects ofestrogens (19).
Over the past 30 years, a large volume of
estrogen-related data has accumulated in the
literature. These data cover molecular biology
to medicine, developmental roles to adverse
effects, evolutionary conservation to repro-
duction, and many other diverse and impor-
tant disciplines. This huge estrogen database
could be transformed into a knowledge base
for regulatory and research purposes in part
by understanding the basis ofthe relationship
between chemical structure and estrogenic
activity. Quantitative structure-activity rela-
tionship (QSAR) analysis correlates chemical
structure and a specific biological activity,
and the derived models are used to predict
activities ofuntested chemicals. Ultimately, it
is reasonable to expect that a number ofsuch
models may be necessary to cover a number
ofpossible mechanisms ofeffects ofchemicals
on estrogenicity (e.g., ER-f, aromatase inhi-
bition, etc.).
Since the pioneering work of Hansch
and colleagues (20) in the 1960s, QSAR
models have been applied extensively in var-
ious areas in chemistry and biology (21).
For environmental toxicology (22, QSAR is
seen as a scientifically credible tool for pre-
dicting and classifying biological activities of
chemicals when little or no actual data are
available (23). QSAR studies generally
involve two steps: first, descriptors (physico-
chemical parameters) are generated which
encode for chemical structural information;
and second, a statistical regression method
correlates changes in structure with changes
in biological activity. The compounds in the
training set (i.e., the data set selected to con-
struct the QSAR model) should be diverse
both in chemical structure and biological
activity to ensure a statistically robust
model. The QSAR method typically
assumes that chemicals function by a com-
mon mechanism. The model is then validat-
ed by predicting the biological activity for a
test set (i.e., a group of chemicals not
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included among the training-set com-
pounds). Once validated, these QSAR
models can be used to predict activities of
untested chemicals.
Recent advances in computing technol-
ogy have extended dassical QSAR to three-
dimensional QSAR (3D-QSAR) models
that correlate the role of molecular shape
with some endpoints which are usually bio-
logical in nature. A widely used approach
for generating descriptors based on the
three-dimensional structural information of
molecules is comparative molecular field
analysis (CoMFA) (24), which is recog-
nized as a versatile and powerful tool in
rational drug design (25) and related appli-
cations (26). CoMFA implicitly assumes
that the ligand-receptor interaction is pri-
marily noncovalent in nature, shape depen-
dent, and invariant across the set of com-
pounds under examination. To construct a
CoMFA model, a collection ofcompounds
with known activities (i.e., the training set)
are first aligned together, usually employing
structure similarity as the basis for align-
ment. The aligned molecules are then
embedded in a three-dimensional grid, after
which the steric and electrostatic fields are
computed for each compound at every grid
point surrounding the molecules. The vari-
ations in these computed steric-electrostatic
fields are then correlated with variations in
the observed biological activity [e.g., ERrel-
ative binding affinity (RBA)] using the
multivariate (linear) regression technique of
partial least-square (PLS), thus forming the
basis ofa statistical model potentially capa-
ble of predicting the biological activity of
compounds outside ofthe training set.
Several CoMFA models have been
developed for both natural and synthetic
estrogens (27-31) and for related steroids
and their receptors (32-34). However,
these studies either included limited struc-
tural diversity in the training set or were not
validated with a test set. There has been lit-
tle effort to examine the relationships
between estrogen binding across receptors
from different species although this is an
important issue inasmuch as interspecies
extrapolation is one ofthe major sources of
uncertainty in risk assessment.
The present study is the first in a series
from our Estrogen Knowledge Base (EKB)
program thatseeks to rationalize the relation-
ship between a structurally diverse set of
estrogenic compounds and their RBAs to the
ER using QSAR approaches. The ultimate
goal ofthis EKB program is to derive com-
putational models for estrogenicity that will
serve as predictive tools to screen a large
number of natural and synthetic chemicals
from numerous structural classes. These tools
will help identify chemicals that exhibit a
high potential for binding to the estrogen
receptor. The actual RBA will need to be
established by binding studies and/or other
short-term measures such as reporter gene or
MCF-7 cell proliferation assays. Although
the literature contains many different end-
points for biological activity, few data sets
exist for large numbers of estrogens assayed
under identical conditions. For this reason,
we developed aQSARmodel based on aspe-
cific endpoint from a single animal model,
i.e., RBA data from calf ER. Subsequently,
this model was used to predict RBAs in
human ER. Success here may allow large
data sets to be built from smaller sets, and by
analogy with meta-analysis in epidemiology,
we might thereby increase the resolving
powerofthe model.
Because models developed with CoMFA
are sensitive to alignment that can be some-
what arbitrary and discretionary (35),
CoMFA results are difficult to duplicate.
For this reason, we concurrently evaluated
classical QSAR that uses physicochemical
parameters in the formulation of regression
equations and requires no alignment step. In
the recent past, the CODESSA program
(Comprehensive Descriptors for Structural
and Statistical Analysis; Semichem,
Shawnee, KS) has been successfully used in
quantitative structure-property relationship
(QSPR) studies to predict normal boiling
points (36), gas chromatographic retention
times (37), and glass transition tempera-
tures (38), among other physical properties
of compounds. We investigated the utility
of the CODESSA-generated descriptors for
QSAR studies and as a complementary tool
to understand ERbindingofestrogens.
Materials and Methods
Data setsfor analysis. von Angerer and co-
workers (39-41) have sought to develop
potent antiestrogens based on nonsteroidal
structures. Among their prototype structures
are the 2-phenylindoles, for which extensive
structure-activity relationship (SAR) studies
have been done (39). We selected 53 estro-
genic compounds from von Angerer's data-
base as the training set to determine the
steric and electrostatic requirements for
recognition at the ER binding site. In most
previous CoMFA studies of ER binding
(27-31), the data sets either consisted of
congeneric compounds or were not ofgood
quality, which limited the general applicabil-
ity of these models to serve as screens for
potential estrogens. In the presentstudy, sev-
eral naturally occurring and synthetic estro-
gens (Fig. 1) were added to the 2-phenylin-
doles to increase the structural diversity and
to span a larger range ofRBA values within
the training set. The chemical structures of
the 53 compounds, organized by chemical
class, are shown in Figure 1 and Tables 1
and 2. The RBAs were calculated from a calf
uterine estrogen receptor (calfER) competi-
tive binding assay with [3H]171-estradiol
(E2). The RBA is the ratio ofthe molar con-
centrations ofE2 and the competing chemi-
cal required to decrease the receptor-bound
radioactivity by 50%, multiplied by 100;
thus, E2has an RBAof100.
The test set comprised the 16 estrogenic
compounds shown in Figure 2. Among
these, the RBA values for 14 steroidal com-
pounds were measured in a competitive ER
binding assay using human MCF-7 cell
cytosol (42). The binding affinities of4 of
the 16 compounds, estrone, estriol, moxe-
strol, and zindoxifen, were measured in the
same calf ER binding assay used in the
training set. Within the test set, only two
estrogens, estrone and estriol, were mea-
sured in both binding assays.
Molecular modeling. The structures of
the 2-phenylindole analogs were constructed
from the Sybyl 6.1 fragment database
(Tripos Inc., St. Louis, MO ). The remain-
ing compounds were built based on the
crystal structures of estradiol and DES,
OH
17
3QB
HO R
R = H 17U-estradiol (E2)
R =(CH2)10-CON(CH3)C4H9 ICI 164, 384
R =(CH2)9-SO-(CH2)3C2F5 ICI 182, 780
R = H Tamoxifen
R = OH 4-Hydroxytamoxifen
Hexestrol
Figure 1. Chemical structures of steroidal and
nonsteroidal estrogens inthetraining set.
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Table 1. Hydroxy-2-(hydroxyphenyl)indole deriva-
tives inthetraining set
R2
3 3' y
x 4'd,/
6N N 1'
Ri
X,Y=OH Position of
Compounds R1 R2 X Y
la H H 6 4
2a H CH3 6 4'
3a H C2H5 6 4'
4a H H 5 4'
5a H CH3 5 4'
6a CH3 H 6 4'
7a C2H5 H 6 4'
8a C3H7 H 6 4'
9a C4HA H 6 4'
1Oa CH3 CH3 6 4'
lla C2H5 CH3 6 4'
12a C3H7 CH3 6 4'
13a i-C3H7 CH3 6 4'
14a CH3 C2H5 6 4'
15a C2H5 C2H5 6 4'
16a C3H7 C2H5 6 4'
17a CH3 H 5 4'
18a C2H5 H 5 4'
19a C3H7 H 5 4'
20a CH3 CH3 5 4'
21a C2H5 CH3 5 4'
22a C3H7 CH3 5 4'
23a i-C3H7 CH3 5 4'
24a C4HA CH3 5 4'
25a C5H11 CH3 5 4'
26a C2H5 C2H5 5 4'
27a C3H7 C3H7 5 4'
28a C2H5 CH3 7 4'
29a C2H5 H 6 3'
30a CH3 CH3 6 3'
31a C2H5 CH3 6 3'
32a C3H7 CH3 6 3'
33a C2H5 H 5 3'
34a CH3 CH3 5 3'
35a C2H5 CH3 5 3'
36a C H7 CH3 5 3'
ZK119,010 (CH2)6N CH2CH2)2 CH3 5 4'
which were obtained from the Cambridge
Structural Database (CSD; University
Chemical Laboratory, Cambridge, U.K.).
Because a single conformation is assumed in
CoMFA studies for a ligand binding to a
receptor, a binding conformation of the
molecules being studied must be postulated
(29). In the absence of experimental evi-
dence on the binding conformation ofestro-
gens, we used the structure based on the
global minimum-energy conformation,
which is standard practice in CoMFA stud-
ies (24). The global minimum-energy con-
formation was computed in three steps: 1)
the geometry of each molecule was opti-
mized to its nearest local minimum-energy
conformation to an energygradient of0.001
kcal/mol A using the standard Tripos mole-
cular mechanics force field with a distance-
dependent (1/r) dielectric function; 2) these
energy-minimized structures were then sub-
jected to conformational analysis using a sys-
tematic search over all rotatable bonds at
100 increments; and finally, 3) the molecules
were reminimized by setting to their identi-
fied minimum-energy torsion angles. All
atomic partial charges were computed using
the Gasteiger-Marsili method (43).
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- ~~~~OH .....
.et0 ;"' ,'........................................... .';.s,,'y@
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Table 2. Diacetoxy-12-formyl-5,6-dihydroindo-
lo[2,1-o]isoquinolines in the training set
CHO
Compounds R1 R2 R3
lb OCOCH3 H CH3
2b H OCOCH3 CH3
3b OCOCH3 H C2H5
4b H OCOCH3 C2H5
5b OCOCH3 H C3H7
6b H OCOCH3 C3H7
7b OCOCH3 H C4HA
8b H OCOCH3 C4HA
9b OCOCH3 H C5H
10b H OCOCH3 C5H11 Figure 2. Chemical structures ofthe compounds in the test set.
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CoMFA alignment anddescriptors. To
perform a CoMFA study, the molecules of
interest must first be aligned to maximize
superposition oftheir steric and electrostat-
ic fields. The alignment procedure varies
from molecule to molecule based on struc-
tural similarity or diversity. Most align-
ment rules employ a least-squares fitting of
pharmacophoric elements between a desig-
nated template molecule (here E2, Fig. 1)
and each of the other molecules in the
training set. The pharmacophoric points of
E2 used for alignment were the centroids of
the A- and D-rings and the C7 atom ofthe
B-ring. This superposition provides maxi-
mal overlap of the rings and their sub-
stituents for the 2-phenylindoles (Tables 1,
2), the steroidal antiestrogens, ICI
182,780, ICI 164,384, and the triph-
enylethylene antiestrogens tamoxifen
(TAM) and 4-hydroxytamoxifen (OH-
TAM) (Fig. 1). For the 2-phenylindoles,
the corresponding alignment points are the
centroid of the phenyl ring of the indole
moiety, the centroid of the 2-phenyl ring,
and the indole nitrogen. The steroidal
estrogens in Figure 1 were aligned in a sim-
ilar manner. For the triphenylethylenes, the
equivalent points are the centroids of the
A- and C-rings, and the C1 atom ofthe B-
ring (or ofthe ethyl group in hexestrol).
This fitting procedure was followed by a
field fit optimization to the template mole-
cule. The field fit adjusts the geometry of
the molecules to maximize the similarity of
the steric and electrostatic fields between
the template and training molecules.
Because this procedure sometimes causes
structural distortions, the molecules were
subsequently reoptimized to relax the fitted
molecules to the nearest local minimum-
energy structure.
After alignment, the molecules were
placed in a three-dimensional cubic lattice
with 2 A spacing. The steric and electrosta-
tic fields were calculated at each mesh
point using an sp3 carbon probe with +1.0
charge based on the van der Waals (LJ 12-6
potential) interactions and Coulombic
interactions, respectively. The steric and
electrostatic energy values were truncated
to 30 kcal/mol.
PLS-QSAR To form the basis for a pre-
dictive statistical model, the method ofpar-
tial least squares (PLS) regression (44) was
used to analyze the training set of 53 com-
pounds by correlating their biological activ-
ities to the steric and electrostatic fields. In
CoMFA studies, the number ofsteric-elec-
trostatic field descriptors (independent vari-
ables, vector X) derived from the CoMFA
field calculations is much larger than the
number of training set compounds with
associated activity data (dependent vari-
ables, vector Y). In this situation, PLS is
particularly well suited to correlate these
field variables with biological activity. PLS
reduces the descriptors to a few principal
components (PCs), which are linear combi-
nations of the original descriptor variables
and, hence, establishes a linear relationship
between Y and X through these PCs. In
order to determine the optimum number of
PCs that yielded the smallest standard error
of prediction, the leave-one-out (LOO)
cross-validation procedure (45) was used.
In this method, each compound is system-
atically excluded once from the data set,
after which its activity is predicted by a
model derived from the remaining com-
pounds. Therefore, the cross-validated r2
(termed q2 hereafter) can be derived from:
q2 = (SD- PRESS)/SD
where PRESS is the sum of squared differ-
ences between the actual and predicted
activity data for each molecule during LOO
cross-validation, and SD is the sum of
squared deviations between the measured
and mean activities ofeach molecule in the
training set. Based on the optimal number
ofprincipal components derived from LOO
cross-validation, the final PLS analysis was
carried out without cross-validation to gen-
erate a predictive QSAR model with a con-
ventional (correlation coefficient) r2. The
correlation, in turn, was used to plot
CoMFA color contours of the steric and
electrostatic field characteristics, which offer
potential insights into the relevant determi-
nants ofbiological activity. The derived 3D-
QSAR model was then employed to predict
the binding affinity values of the 16 com-
pounds in the test set (Fig. 2).
The r2 and q2 are two key measures of
CoMFA model performance. The r2 mea-
sures the model's goodness offit to the train-
ing set activitydata, with avalue ofr2 greater
than 0.9 normally indicating statistical signif-
icance. The q2 is derived from the LOO
cross-validation procedure, in which the sta-
bilityofthe model is tested byperturbing the
regression coefficients by consecutively omit-
tingeach compound. Consequendy, the q2 iS
a measure of the robustness of the model,
that is, its ability to predict. The q2 is gener-
allylower than the r2, and amodelwith q2 >
0.5 is normally considered to have a signifi-
cantpredictive ability (24).
Calculation ofCODESSA descriptors. In
the present application of the CODESSA
methodology, as many as 365 descriptors
were calculated for each compound in the
training set. These descriptors were in one of
the following categories: constitutional,
topological, geometrical, electrostatic, and
quantum-chemical. Most applications for
these descriptors have so far been for QSPR
rather than QSARstudies. The simplest type
are the constitutional descriptors, e.g., atom
counts, molecular weight, etc., which reflect
the molecular composition ofthe compound
without regard to its geometry or electronic
structure. For each molecule, topological
descriptors include the Kier and Hall,
Randic, and Wiener indices, which are most
sensitive to molecular connectivity.
Geometrical descriptors, such as the moment
of inertia, molecular surface area, etc.,
require the 3D-coordinates of the atoms in
the molecule. The electrostatic descriptors
reflect the characteristics of charge distribu-
tion and can be calculated usingone or more
nonempirical procedures within the
CODESSA program or by any quantum-
chemical program. Quantum chemical
descriptors add important information to the
conventional descriptors in terms of the
internal electronic properties of molecules,
which is otherwise not obtainable. To gener-
ate quantum chemical descriptors in the
CODESSA program, all Sybyl energy mini-
mized structures were submitted to semiem-
pirical quantum chemical calculation with
optimization using the AMI model
Hamiltonian in AMPAC (Semichem,
Shawnee, KS). The set ofCODESSAmolec-
ular descriptors were autoscaled, then LOO
cross-validation (45) was carried out to
determine the optimum number of PCs.
The final QSAR model was determined by
means ofPLS without cross-validation.
Results
CoMFA-PLS. Table 3 contains a compari-
son of the RBAs (expressed as log RBA)
predicted for the training set compounds
using CoMFA-PLS with the corresponding
experimental values. The largest log RBA
residual is 0.41 (26a and 36a), correspond-
ing to a maximum RBA variation of 2.6-
fold between calculated and experimental
values. A plot of the calculated versus
experimental RBAs is given by the open
symbols in Figure 3. The correlation has a
high r2 (0.97) and q2 (0.61), which indi-
cates significant self-consistency and pre-
dictive capability. The CoMFA-PLS model
required nine principal components to
explain the variance in biological activity.
The other statistical parameters associated
with this model are standard error (SE) =
0.16, F= 130.3, andp<0.001.
The steric and electrostatic field contri-
butions to the CoMFA model were 44%
and 56%, respectively. The substantial
contribution from the electrostatic fields is
consistent with previous CoMFA models
of ER binding (29-31). Figure 4 shows a
color-coded three-dimensional contour
map depicting regions in space around the
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inner green region indicating that the pres-
ence ofsteric bulk in this region, such as the
ethyl substituents in compounds 7a or 1la,
will enhance RBA. Beyond the green region
is a yellow region where additional steric
bulk, such as in compounds 9a or 24a, will
diminish RBA.
The red and blue polyhedra describe
regions ofspace where an increase in nega-
tive charge is associated with increased and
decreased RBA, respectively. The blue con-
Table 3. Observed and calculated relative binding affinities (RBAs)forthe calfestrogen receptorofthetraining
setfor both CoMFAand CODESSA models
CoMFA-PLS
Experimental log RBA
-2.00
-1.22
-0.89
-2.00
-1.22
0.58
1.20
0.93
0.63
1.00
1.52
1.11
1.11
0.77
1.32
1.28
-0.10
0.76
1.25
0.66
0.98
1.20
0.54
0.66
0.36
1.36
0.23
-1.70
0.23
-0.26
0.48
0.54
0.23
-0.22
0.34
0.87
1.32
0.23
0.59
0.11
0.52
-0.30
0.42
-0.15
0.32
-0.22
0.28
2.00
0.75
0.79
-0.44
0.83
1.34
Calculated log RBA
-2.21
-1.12
-1.07
-1.80
-1.01
0.53
1.21
0.95
0.70
0.80
1.39
1.11
0.86
0.81
1.30
1.34
0.13
0.73
0.86
0.60
0.93
1.24
0.77
0.74
0.58
0.96
0.55
-1.74
0.27
-0.36
0.81
0.74
0.25
-0.13
0.30
0.46
1.51
0.28
0.62
0.14
0.56
-0.25
0.27
-0.04
0.26
-0.26
0.17
1.95
0.67
0.72
-0.51
1.00
1.41
CODESSA-PLS
Residual
0.21
-0.10
0.18
-0.20
-0.21
0.05
-0.01
-0.02
-0.06
0.20
0.13
0.0
0.25
-0.04
0.02
-0.06
-0.23
0.04
0.40
0.06
0.05
-0.03
-0.23
-0.08
-0.22
0.41
-0.32
0.04
-0.04
0.10
-0.33
-0.20
-0.02
-0.09
0.05
0.41
-0.19
-0.05
-0.03
-0.03
-0.04
-0.05
0.15
-0.11
0.06
0.04
0.11
0.05
0.08
0.07
0.07
-0.17
-0.06
Calculated log RBA
-2.15
-1.22
-0.59
-2.17
-1.19
-0.05
0.55
0.70
0.82
0.40
0.67
0.84
0.75
0.68
0.83
0.96
0.00
0.45
0.67
0.35
0.65
0.79
0.80
0.89
0.84
0.81
0.91
0.58
0.55
0.36
0.67
0.88
0.46
0.33
0.69
0.83
0.85
0.02
0.26
0.20
0.47
0.28
0.36
0.31
0.38
0.31
0.43
1.73
0.82
0.54
-0.08
0.27
1.48
Residual
0.15
0.0
-0.30
0.17
-0.03
0.63
0.65
0.23
-0.19
0.60
0.85
0.28
0.36
0.09
0.50
0.32
-0.10
0.31
0.58
0.32
0.33
0.42
-0.25
-0.23
-0.48
0.56
-0.68
-2.28
-0.32
-0.62
-0.19
-0.34
-0.23
-0.55
-0.34
0.04
0.47
0.21
0.33
-0.09
0.05
-0.58
0.06
-0.46
-0.06
-0.53
-0.15
0.27
-0.07
0.25
-0.36
0.56
-0.13
tour surrounding the 3'-position of the
phenyl moiety of the 2-phenylindoles sug-
gests that the presence of the OH sub-
stituent at this position decreases RBA and
gives a rational explanation for the lower
RBA of compounds 29a to 36a compared
with the corresponding analogs where sub-
stitution is at the 4'-position (compounds
7a, lOa-12a, 18a, and 20a-22a).
The CoMFA model so derived was
used to predict the activity ofthe test com-
pounds shown in Figure 2. Since four com-
pounds (estrone, estriol, moxestrol, and
zindoxifen) were assayed identically to
those in the training set, they provide an
additional means to assess the predictive
significance of the model. There is very
good agreement between the actual and
predicted RBA values for these four test
compounds with small residuals similar to
that obtained for the training set results
(Fig. 3 and Table 4). The model predicted
estrone, estriol, and moxestrol to have
moderate binding affinities, while zindox-
ifen is predicted to have relatively weak
receptor binding.
As seen in Table 4, two ofthe four test
compounds, estrone and estriol, were
assayed with both calfand human ER. The
RBA values obtained from both receptor
assays are comparable. The availability of
these data prompted us to take our model a
step further by exploring the interspecies
relationship for estrogen receptor binding.
Hence our calf ER-derived CoMFA model
was used to predict calfER RBAs for the 14
compounds in Table 4 that had available
RBAs for human ER. A comparison ofthe
predicted calfER RBA versus experimental
human ER shows a positive correlation
with a coefficient of0.80. Compounds that
bind poorly or show no binding affinity to
human ER (e.g., estratrine, androstane)
were predicted to bind similarly with the
calfER, as were compounds that had mod-
erate bindingaffinitywith human ER.
CODESSA-PLS. The CODESSA-PLS
model for the same set of 53 compounds
required three principal components to
explain the variance in biological activity. As
in CoMFA-PLS, the optimum number of
components was determined using the LOO
cross-validation procedure. The key statisti-
cal parameters for this model are q2 = 0.54,
r2= 0.68, SE = 0.55, F= 30.3, andp<0.001.
The CODESSA results for the calculated log
RBAs are likewise given in Table 3. Aplot of
the experimental versus calculated RBA val-
ues for the training set compounds is shown
in Figure 5. It can be seen that there is an
obvious outlier in compound 28a. Removing
this compound from the training set
improved the conventional r2 (0.80). Table
1 shows that compound 28a is the only one
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molecules where the variations in steric and
electrostatic fields are most strongly corre-
lated with variations in log RBA; an E2
template molecule provides geometrical ref-
erence. The green and yellow polyhedra
describe regions in space where increased
steric bulk increases or decreases the RBA,
respectively. Clearly, ligand-ER binding is
sensitive to the length ofthe substituents at
the indole N-1 position and at the steroid
B-ring. This position is surrounded by an
Compounds
la
2a
3a
4a
5a
6a
7a
8a
9a
10a
Ila
12a
13a
14a
15a
16a
17a
18a
19a
20a
21a
22a
23a
24a
25a
26a
27a
28a
29a
30a
31a
32a
33a
34a
35a
36a
ZK 119,010
lb
2b
3b
4b
5b
6b
7b
8b
9b
10b
E2
ICI 164,384
ICI 182,780
TAM
OH-TAM
Hexestrol
Abbreviations: PLS, partial leastsquares; E2,170-estradiol; TAM,tamoxifen; OH-TAM, 4-hydroxytamoxifen.
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Figure 4. CoMFA steric and electrostatic contour
plots for binding affinitywith the structure of 17l-
-2 -2 - o westradiol shown inside the field. Enhanced rela-
tive binding affinity (i.e., higher binding affinity) is
associated with adding/subtracting steric bulk
from green/yellow regions and with adding/sub-
tracting positive charge in the blue/red regions.
-3 The absence of color represents regions that
3 2 -1 0 1 2 3 were unexamined bythe current data set.
Experimental leg RBA
Figure 3. Plot of observed log relative binding affinity (log RBA) versus CoMFA-calculated log RBA for calf
estrogen receptor. i2 = 0.97; q2 = 0.61. Percentage contribution from steric, 44%; from electrostatic, 56%.
in which the OH-substituent is at the 7-
position. It appears that the difference in the
position ofthis functional group, while pos-
sibly encoded in the descriptors, cannot be
easily distinguished by the CODESSA
methodology. Indeed, for compounds 1la,
21a, and 28a, for example, where only the
position of substituent X is changing, i.e.,
positions 6, 5, and 7, respectively, the calcu-
lated log RBA values are close to each other
(calculated log RBA = 0.67, 0.65, and 0.58,
respectively). On the contrary, the experi-
mental RBAvalues for these compounds sig-
nificantly decrease as the OH-substituent is
moved from the 6-, 5-, and 7-positions
(experimental log RBA = 1.52, 0.98, and -
1.70, respectively).
The CODESSA-PLS methodology gives
the PLS X-loadings, which were examined in
order to delineate the relative contribution of
each molecular descriptor to the regression
model. The molecular descriptors with high-
ly positive or highly negative PLS loadings
(regarded as the most important) were asso-
ciated with the quantum chemical and elec-
trostatic descriptors that encode the features
responsible for polar interactions between
molecules. This is consistent with the
CoMFA results in which the electrostatic
field had a greater contribution to estrogenic
activity than did steric fields.
Table 4. Comparison of experimental log relative binding affinity (log RBA) for both the calf estrogen recep-
tor(ER) and the human ER and the predicted log RBA obtained from CoMFA and CODESSA models
Number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Compounds
17P-Estradiol
17a-Estradiol
16a-Estradiol
1-OH-Estradiol
2-OH-Estradiol
4-OH-Estradiol
3-Hydroxyestratrien
Estratrien-170-ol
Estratrien
Estrone
Estriol
5-Androstene-30,17fi-diol
5a-Androstane-3p,17p-diol
5a-Androstane-3a,170-diol
Moxestrol
Zindoxifen
Experimental log RBA
Human ER Calf ER
2.00
1.34
1.90
-0.30
1.85
0.84
1.90
1.04
<-1.30
1.34
1.23
-0.16
-0.30
<-1.30
Predicted log RBA
CoMFA-PLS CODESSA-PLS
2.00 1.95
1.60
0.89
0.31
0.95
1.50
1.27
0.51
-0.17
1.11 1.68
1.11 1.24
-0.67
-0.15
-0.35
1.11 1.27
0.23 0.20
1.75
1.75
1.78
1.62
2.18
2.05
1.16
1.21
-0.10
0.94
1.70
1.99
1.94
1.82
1.37
0.30
PLS, partial leastsquares.
While the CODESSA descriptors are
able only to explain 68% ofthe variation in
the activity, the model is potentially capable
of predicting the activity of compounds
outside the training set, as demonstrated by
the significant q2 of 0.54. Figure 5 shows
that there is good agreement ofthe predict-
ed values with the experimental RBA in calf
uterine cytosol for estrone, estriol, moxe-
strol, and zindoxifen.
As we already observed in the training
set, the CODESSA-PLS model appears rel-
atively insensitive to the position of sub-
stituents. This inherent limitation manifests
itselfin the predictions for compounds 1-6
(Table 4), which differ from one another
only by the position ofthe hydroxyl group.
The RBA values predicted by CODESSA-
PLS for all these compounds are not signifi-
cantly different from each other. However,
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Figure 5. Plot of experimental versus CODESSA calculated log relative binding afffinity (log RBA) values
for calf estrogen receptor (ER). ,2 = 0.68; q2
= 0.54.
the experimental RBA values for com-
pounds 1-OH-estradiol and 4-OH-estradi-
ol (compounds 4 and 6) are much lower
than the RBA for E2. Another notable dis-
parity pertains to the androgenic com-
pounds (compounds 12, 13, and 14 in
Table 4), whose structures are very similar
to E2 except that the A-ring is not aromat-
ic. Although these compounds have poor
binding affinities, their predicted RBAs are
close to that of E2. This prediction of
abnormally high RBAs may be likely for
these analogs because a structure with a
nonaromatic A-ring was not represented in
the training set.
Discussion
For this series of estrogenic chemicals,
CoMFA demonstrated a significant corre-
lation ofits calculated steric and electrosta-
tic fields with RBA and provided predic-
tions in good agreement with experimental
values, for calfER RBAs. CaLculated RBAs
differed by less than 2.6-fold from experi-
mental values, which traversed a 10,000-
fold range. The CoMFA coefficient con-
tour plots revealed a consistent pattern of
the chemical features largely responsible for
the variations in RBAwith E2 as a template
molecule (Figure 4). These features gener-
ally fall within three regions around the A,
B, and D rings. The upper middle position
ofthe molecule was relatively insensitive to
structural changes. For the 2-phenylin-
doles, this result is consistent with previous
observations that short alkyl groups in the
indole N-1 position increase binding while
there is a decrease in affinity with com-
pounds containing more than three carbon
atoms in the indole N-1 side chain (39).
The present results demonstrate the
potential capability of QSAR models to
rapidly assess the potential for compounds
to bind to the ER. This capability clearly
distinguishes the QSAR model from the
actual measurement of RBAs, in vitro
reporter gene and cell proliferation activi-
ties, or in vivo endpoints. Screening chemi-
cals for their RBAs by use ofQSAR models
shows promise in terms of reducing the
enormous time and expense oftesting each
and every compound exhaustively. As men-
tioned above, we recognize that those com-
pounds identified by QSAR as binding to
the ER will still require further experimen-
tal confirmation by laboratory studies. For
this reason, QSAR models must be consid-
ered as only one component of a compre-
hensive screening and testing system that
will determine the estrogenic impact of a
compound on a particular species. It is
hoped that QSAR models can serve as fast
and reliable screens to identify those chem-
ical structures most likely to exhibit estro-
genic activity and to prioritize compounds
for subsequent biological testing on the
basis of their predicted RBAs. For these
reasons, the level of precision required
from a QSAR model will vary depending
on the intended purpose.
We established a correlation between
the predicted RBA values for calf ER and
their actual RBA values for human ER.
The largest difference observed between the
two estrogen receptor sources is that for
compound 16a-estradiol, whose predicted
binding affinity is 10-fold below that
found with human ER. This deviation is
not strikingly larger than the 2.6-fold error
in the calf ER RBA calculation. This may
be due to species difference or in part to
the lack of information in the training set
regarding substituents at the 16-position of
the steroid structure. This finding rein-
forces the necessity of having a diverse set
of training molecules and suggests a ratio-
nal way to evaluate which additional data
would strengthen the model.
While further validation (by expanding
the number ofcompounds) is needed, the
satisfactory correlation across species indi-
cates only a limited range ofvariability of
RBAs for these two receptor sources. This
is almost certainly a consequence of the
well-defined evolutionary conservation of
the ER primary structure (amino acid
sequence) across avariety ofspecies and the
broader conservation of primary structure
across a number ofreceptors that constitute
the steroid hormone receptor superfamily
(46). For example, there is only a seven-
amino acid difference in the primary struc-
tures of ligand-binding domains between
the human and murine ER (47,48).
Prediction of chemical binding to the
ER is important for regulatory purposes.
Use of literature data sets obtained with
comparable assays across species increases
the number of chemical structures con-
tributing to the model. Importantly, this
may generate a set of metrics that improve
interspecies extrapolation, a significant
problem in risk assessment. This approach
is therefore relevant to the development of
tools to identify potential endocrine disrup-
tors for subsequent evaluation, which, by
virtue ofwide environmental exposure, may
act in alarge number ofanimal species.
The QSAR models described here were
developed to predict ER RBAs for numer-
ous chemicals that have not been examined
for estrogenic activity. In particular, legisla-
tion passed in 1996 requires the EPA to
define a testing scheme for estrogenicity
within 2 years (10,11). Hence, models such
as these offer a means to prioritize among a
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large number of chemicals, based on their
potential as ER ligands, for testing in more
expensive assays arranged in a tiered battery,
with the most definitive in vivo tests at the
apex. For this initial screening purpose, cri-
teria must be developed for decision points
for RBA values. This is not as straightfor-
ward as it may seem because other events,
such as serum binding or metabolism, can
alter potency. For example, in developing
animals, some xenoestrogens show greatly
increased potency relative to E2 due to the
presence of high affinity serum binding
proteins for E2, which bind xenoestrogens
with much lower affinity (49).
Regardless of the criteria applied to
RBA values to define a chemical as estro-
genic, it should be appreciated that perfect
predictivity of RBAs is not required at the
initial screening step. Rather, the incidence
offalse negatives (actual ER binding chem-
icals that appear negative in the screen) is
of greatest concern, as these may not be
further tested in a timely way. False posi-
tives (classifying a chemical as an ERligand
if the chemical actually does not bind) are
ofmuch less concern; they would be elimi-
nated at higher tiers in the test battery. We
are designing additional approaches that
can be used in conjunction with the QSAR
models such as described here to help in
determining criteria for selecting chemicals
for more extensive testing.
Our analysis indicates that the COMFA
model is superior in precision to the
CODESSA model for the present applica-
tion. It appears that the CODESSA descrip-
tors as implemented in the PLS procedure
were unable to capture those factors that
influence the variations in RBA and, there-
fore, limit the correlation between the RBAs
and certain structural differences in the train-
ing set. It may also be possible that a nonlin-
ear relationship exists between the descrip-
tors and RBAs, which can be addressed by
other nonlinear regression methods such as
artificial neural networks.
Compared with CODESSA-PLS,
CoMFA appears better able to explain
estrogen receptor binding variation in terms
of the steric and electrostatic requirements.
However, when used in appropriate cases,
CODESSA-PLS is certainly less prone to
arbitrariness (e.g., alignment) and is proce-
durally less difficult to implement.
Importantly, the level of precision with
CoMFA seems more than adequate for the
intended purpose, while the range of pre-
dictability of RBAs at 10,000-fold is quite
large. Further development ofthis model is
currently underway.
In summary, we have shown the feasi-
bility of using computational methods to
predict the RBAs ofchemicals untested for
estrogenic activity. Such predictions should
allow selection ofthe highest priority chem-
icals for testing, resulting in information on
estrogenic activity to be obtained more
quickly than ifno priority criteria existed.
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